CombiGene AB (publ)

DB:COJ0 Stock Report

Market Cap: €4.0m

CombiGene Management

Management criteria checks 1/4

CombiGene's CEO is Peter Ekolind, appointed in Sep 2023, has a tenure of 1.33 years. total yearly compensation is SEK893.49K, comprised of 80.6% salary and 19.4% bonuses, including company stock and options. directly owns 0.22% of the company’s shares, worth €8.96K. The average tenure of the management team and the board of directors is 1.3 years and 0.8 years respectively.

Key information

Peter Ekolind

Chief executive officer

SEK 893.5k

Total compensation

CEO salary percentage80.6%
CEO tenure1.3yrs
CEO ownership0.2%
Management average tenure1.3yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Peter Ekolind's remuneration changed compared to CombiGene's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 37m

Jun 30 2024n/an/a

-SEK 37m

Mar 31 2024n/an/a

-SEK 35m

Dec 31 2023SEK 893kSEK 720k

-SEK 36m

Compensation vs Market: Peter's total compensation ($USD80.47K) is below average for companies of similar size in the German market ($USD462.70K).

Compensation vs Earnings: Insufficient data to compare Peter's compensation with company performance.

CEO

Peter Ekolind (60 yo)

1.3yrs

Tenure

SEK 893,492

Compensation

Mr. Peter Ekolind served as Chief Operating Officer at CombiGene AB (publ) since September 27, 2022 and serves as its Chief Executive Officer since September 01, 2023. He serves as Chief Executive Officer...

Leadership Team

NamePositionTenureCompensationOwnership
Peter Ekolind
Chief Executive Officer1.3yrsSEK 893.49k0.22%
€ 9.0k
David Woldbye
Scientific Founderno datano datano data
Merab Kokaia
Scientific Founderno datano datano data
Louise Aspenberg
Chief Financial Officer5yrsno datano data
Annika Ericson
Chief Scientific Officerless than a yearno datano data

1.3yrs

Average Tenure

60.5yo

Average Age

Experienced Management: COJ0's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Marcus Isaksson
Directorless than a yearno datano data
Andrew Rice
Member of Scientific Advisory Board1.4yrsno datano data
Lars Thunberg
Deputy Board Memberless than a yearSEK 115.51kno data
Annamaria Vezzani
Member of Scientific Advisory Boardno datano datano data
Margitta Seeck
Member of Scientific Advisory Boardno datano datano data
Jakob Bendtsen
Directorless than a yearno datano data
David Bennett
Member of Scientific Advisory Board1.4yrsno datano data
Lars Arendt-Nielsen
Member of Scientific Advisory Board1.4yrsno datano data
Luca Stefano
Chairman of the Boardless than a yearno datano data
Sten Linnarsson
Member of the Scientific Advisory Boardless than a yearno datano data

0.8yrs

Average Tenure

46yo

Average Age

Experienced Board: COJ0's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 16:07
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CombiGene AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Niklas ElmhammerCarlsquare AB